News
Capital Market on MSN2h
Glenmark Pharma receives warning letter from USFDA for Indore facilityIn an official filing, the company stated that it does not anticipate the warning letter will disrupt supply chains or affect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback